Standing On A Ledge Once Again, Amicus Therapeutics, Inc. (FOLD) Holds Breath For Latest Study
8/11/2014 6:52:49 AM
When a biotech’s lead drug candidate fails in a clinical trial, it’s often the death knell for the company. But Cranbury, NJ-based Amicus Therapeutics has eluded the biotech version of the Grim Reaper not just once, but twice, with two different drugs. With each failure, Amicus had to keep things together, downsize, conserve cash, and survive.
Help employers find you! Check out all the jobs and post your resume.
comments powered by